Mesothelioma Cancer Centers
The Stanford Cancer Institute is a cancer treatment and research institute affiliated with the highly respected Stanford School of Medicine in Stanford, California. It is part of the Stanford Hospital & Clinics health system, a 613-bed hospital facility in California’s Bay Area.
Stanford Medicine has a long history that begins more than 150 years ago with the founding of the University of the Pacific’s medical school, which would eventually become part of Stanford. Stanford Hospital dates back to 1919, when the Stanford Home for Convalescent Children opened its doors; over the coming decades the hospital changed ownership several times, eventually becoming Stanford Hospital. In 1959, the medical school and hospital moved from its San Francisco location to new quarters on the Stanford University campus.
Stanford Hospital grew considerably over the years, adding a children’s hospital and building new facilities for outpatient services, psychiatry and other specialties. In 2004, the Stanford Cancer Center was opened, bringing together under one roof all 80 cancer specialties that previously had been scattered throughout the medical center. In 2011, the cancer center’s name was officially changed to the “Stanford Cancer Institute” to underscore its role as one of five institutes at the hospital.
The Stanford Cancer Institute treats mesothelioma patients at their Stanford Clinical Cancer Center. Treatment takes all patient circumstances and wants into account with an individualized approach.
Types of mesothelioma treatment practiced at Stanford include brachytherapy, chemotherapy, external radiation, radiation therapy and video-assisted thoracic surgery (VATS). However, Stanford places a strong focus on clinical trials, where they are developing new treatments for mesothelioma. Patients may be able to undergo experimental treatments at the Stanford Cancer Center, if they are eligible.
For patients who decide to pursue treatment at Stanford Cancer Institute, there are many support groups and other resources like financial assistance to offer help during their treatment journey. All patients at the Stanford Cancer Institute are invited to take part in services from the Cancer Supportive Care Program, a free resource that strives to create a warm and nurturing environment for patients and their families. Offerings include healing-oriented hypnotherapy, writing workshops and even complimentary chair massages.
- Clinical trials
- Video-assisted thoracic surgery (VATS)
- Association of American Cancer Institutes member
- National Cancer Institute Comprehensive Cancer Center designation
- National Comprehensive Cancer Network member
Mesothelioma Clinical Trials at Stanford Cancer Institute
The following clinical trials are in progress or actively recruiting participants at Stanford Cancer Institute:
A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors
Conditions: Advanced Solid Tumors Cancer Last Updated: March 1, 2019 Status: Recruiting
Conditions: Solid Tumors; Triple-Negative Breast Cancer; Non Small Cell Lung Cancer; Renal Cell Carcinoma; Mesothelioma; Fumarate Hydratase (FH)-Deficient Tumors; Succinate Dehydrogenase (SDH)-Deficient Gastrointestinal Stromal Tumors (GIST); Succinate Dehydrogenase (SDH)-Deficient Non-gastrointestinal Stromal Tumors; Tumors Harboring Isocitrate Dehydrogenase-1 (IDH1) and IDH2 Mutations; Tumors Harboring Amplifications in the cMyc Gene Last Updated: July 18, 2018 Status: Active, not recruiting
Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma
Conditions: Mesothelioma; Pleural Mesothelioma Last Updated: July 5, 2018 Status: Active, not recruiting
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette
Stanford Health Care. Mesothelioma.